What is the diagnostic algorithm for persistent hypokalemia?

Diagnostic Algorithm for Persistent Hypokalaemia

Begin by correcting the hypokalaemia to within the normal laboratory reference range, then measure urinary potassium excretion to determine if renal potassium wasting is present 1, 2.

Step 1: Correct Hypokalaemia and Assess Urinary Potassium Loss

• Measure spot urine potassium-to-creatinine ratio (K/Cr): A ratio <1.5 suggests extrarenal losses (poor intake, gastrointestinal losses, or transcellular shift), while a ratio ≥1.5 indicates renal potassium wasting 3.
• Alternatively, calculate 24-hour urinary potassium excretion: >40 mmol/24h indicates inappropriate renal potassium loss 4.
• Correct hypokalaemia before proceeding with further diagnostic testing, as uncorrected hypokalaemia can cause false-negative screening results 1, 2.

Step 2: If Renal Potassium Wasting is Present, Measure Blood Pressure

Hypertensive Patients with Renal Potassium Wasting

Screen for primary aldosteronism (PA) by measuring plasma aldosterone concentration (PAC) and plasma renin activity (PRA) or direct renin concentration (DRC) 1.

Screening Criteria for PA:

• Aldosterone-to-renin ratio (ARR):
  • ARR >20 (aldosterone in ng/dL, PRA in ng/mL/h) when measured by immunoassay
  • ARR >70 (aldosterone in pmol/L, DRC in mU/L) when measured by immunoassay
  • ARR thresholds are ~25% lower when aldosterone is measured by LC-MS/MS 1
• Renin must be suppressed (hallmark of PA) with inappropriately elevated aldosterone 1

Medication Management Before Screening:

• Withdraw interfering medications if safe and feasible:
  • Mineralocorticoid receptor antagonists, ENaC inhibitors, and other diuretics: 4 weeks
  • ACE inhibitors and ARBs: 2 weeks
  • β-blockers and centrally acting α₂-agonists: 2 weeks (these can cause false positives) 1
• Alternative approach: Screen without medication withdrawal if withdrawal is unsafe, though this may reduce accuracy 1

Confirmatory Testing for PA:

• If PAC >20 ng/dL with suppressed renin and spontaneous hypokalaemia: No further confirmatory testing needed—diagnosis of PA is established 2
• For all other positive screens: Perform one of four confirmatory tests:
  • Fludrocortisone suppression test
  • Oral salt loading test
  • Intravenous saline infusion test
  • Captopril challenge test 2

Other Hypertensive Causes:

If PA is excluded, consider:

• Liddle syndrome (low aldosterone, low renin)
• Apparent mineralocorticoid excess
• Cushing syndrome
• Congenital adrenal hyperplasia
• Renal artery stenosis
• Geller syndrome (especially in pregnant women) 4, 3, 5

Normotensive or Hypotensive Patients with Renal Potassium Wasting

Assess acid-base status and urinary chloride excretion 6, 4, 3.

Metabolic Alkalosis Present:

• Measure spot urine chloride concentration:

  • Urine Cl⁻ <33.3 mmol/L (highest diagnostic accuracy, AUC 0.978): Suggests vomiting-related upper gastrointestinal losses 6
  • Serum Cl⁻ <94.9 mmol/L also supports vomiting as the cause (AUC 0.939) 6
  • Urine Cl⁻ >40 mmol/L with K/Cr ≥1.5: Consider diuretic use (screen urine for diuretics), Bartter syndrome, or Gitelman syndrome 3

• Gitelman syndrome (most common genetic cause):

  • Hypomagnesaemia
  • Hypocalciuria (urinary Ca/Cr ratio <0.20 mmol/mmol)
  • Preserved urinary chloride excretion (>40 mmol/24h)
  • Renal sodium and potassium wasting 4

• Bartter syndrome: Similar to Gitelman but typically with normal magnesium and normal-to-high urinary calcium excretion 4, 3

Metabolic Acidosis Present:

• K/Cr <1.5: Lower gastrointestinal losses (diarrhea, laxative abuse) 3
• K/Cr ≥1.5: Consider diabetic ketoacidosis, type 1 or type 2 distal renal tubular acidosis 3

Paralysis Present:

Consider hyperthyroidism, familial periodic paralysis, or sporadic periodic paralysis 3

Step 3: Check Serum Magnesium

Hypomagnesaemia can cause refractory hypokalaemia by increasing urinary potassium losses. Correct magnesium deficiency if present 3.

Common Pitfalls to Avoid

• Failing to correct hypokalaemia before screening: This leads to false-negative results for PA 1, 2
• Improper blood collection technique: Use slow syringe collection (not vacuum tubes), avoid fist clenching, wait ≥5 seconds after tourniquet release, and separate plasma within 30 minutes to avoid spuriously elevated potassium 1
• Not recognizing that most PA patients are normokalaemic: Screening only hypokalaemic patients misses the majority of PA cases 1
• Overlooking medication effects: β-blockers can cause false-positive ARR; diuretics can cause false-negative results 1
• Ignoring chronic kidney disease effects: Both renin and aldosterone can be elevated in CKD, increasing false-positive rates 1

Re-screening Indications

If initial screening is negative, consider re-screening if the patient develops:

• Unexplained worsening or resistant hypertension
• New spontaneous or diuretic-induced hypokalaemia
• Atrial fibrillation without structural heart disease or hyperthyroidism 1